SPY333.92+1.81 0.54%
DIA273.63+1.63 0.60%
IXIC11,095.52+97.12 0.88%

Champions Oncology Q4 Sales $8.80M Beat $8.29M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly sales of $8.80 million which beat the analyst consensus estimate of $8.29 million by 6.15 percent. This is a 14.02 percent increase over sales of $7.72 million the

Benzinga · -
Champions Oncology (NASDAQ: CSBR) reported quarterly sales of $8.80 million which beat the analyst consensus estimate of $8.29 million by 6.15 percent. This is a 14.02 percent increase over sales of $7.72 million the same period last year.